Publications
-
Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial.
Weinblatt ME,
Kavanaugh A, Genovese MC, Jones DA, Musser TK, Grossbard EB, Magilavy DB.
J Rheumatol.
2013;
40
(4):
369-78
-
Effects of sclerostin antibody on healing of a non-critical size femoral bone defect.
Jawad MU,
Fritton KE, Ma T, Ren PG, Goodman SB, Ke HZ, Babij P, Genovese MC.
J Orthop Res.
2013;
31
(1):
155-63
-
Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study.
Stohl W,
Merrill JT, McKay JD, Lisse JR, Zhong ZJ, Freimuth WW, Genovese MC.
J Rheumatol.
2013;
40
(5):
579-589
-
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Genovese MC,
Durez P, Richards HB, Supronik J, Dokoupilova E, Mazurov V, Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T, Hugot S, Mpofu S.
Ann Rheum Dis.
2013;
72
(6):
863-9
-
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure.
Genovese MC,
Rubbert-Roth A, Smolen JS, Kremer J, Khraishi M, Gómez-Reino J, Sebba A, Pilson R, Williams S, van Vollenhoven R.
J Rheumatol.
2013
-
Novel small molecule therapeutics in rheumatoid arthritis.
Kelly V,
Genovese M.
Rheumatology (Oxford).
2013
-
Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial.
Genovese MC,
Bojin S, Biagini IM, Mociran E, Cristei D, Mirea G, Georgescu L, Sloan-Lancaster J.
Arthritis Rheum.
2013;
65
(4):
880-9
-
Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study.
Genovese MC,
Han C, Keystone EC, Hsia EC, Buchanan J, Gathany T, Murphy FT, Wu Z, Parasuraman S, Rahman MU.
J Rheumatol.
2012;
39
(6):
1185-91
-
Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy.
Genovese MC,
Schiff M, Luggen M, Le Bars M, Aranda R, Elegbe A, Dougados M.
J Rheumatol.
2012;
39
(8):
1546-54
-
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors.
Genovese MC,
Fleischmann RM, Greenwald M, Satterwhite J, Veenhuizen M, Xie L, Berclaz PY, Myers S, Benichou O.
Ann Rheum Dis.
2012
-
A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis.
Genovese MC,
Cohen SB, Wofsy D, Weinblatt ME, Firestein GS, Brahn E, Strand V, Baker DG, Tong SE.
J Rheumatol.
2011;
38
(5):
846-54
-
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.
Genovese MC,
Kavanaugh A, Weinblatt ME, Peterfy C, DiCarlo J, White ML, O'Brien M, Grossbard EB, Magilavy DB.
Arthritis Rheum.
2011;
63
(2):
337-45
-
Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial.
Genovese MC,
Kinnman N, de La Bourdonnaye G, Pena Rossi C, Tak PP.
Arthritis Rheum.
2011;
63
(7):
1793-803
-
Reply.
Genovese M,
Arthritis Rheum.
2011
-
Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.
Genovese MC,
Covarrubias A, Leon G, Mysler E, Keiserman M, Valente R, Nash P, Simon-Campos JA, Porawska W, Box J, Legerton C, Nasonov E, Durez P, Aranda R, Pappu R, Delaet I, Teng J, Alten R.
Arthritis Rheum.
2011;
63
(10):
2854-64
-
An oral syk kinase inhibitor in the treatment of rheumatoid arthritis: A 3 month randomized placebo controlled phase 2 study in patients with active RA who had failed biologic agents.
Genovese MC,
Kavanaugh A, Weinblatt ME, Peterfy C, Dicarlo J, White ML, O-Brien M, Grossbard EB, Magilavy DB.
Arthritis Rheum.
2010
-
In Memoriam: Edward D. Harris Jr., M.D., 1937- 2010.
Genovese MC,
Moynihan E.
Arthritis Rheum.
2010
-
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study.
Genovese MC,
Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P, Sloan-Lancaster J.
Arthritis Rheum.
2010;
62
(4):
929-39
-
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.
Hueber W,
Tomooka BH, Batliwalla F, Li W, Monach PA, Tibshirani RJ, Van Vollenhoven RF, Lampa J, Saito K, Tanaka Y, Genovese MC, Klareskog L, Gregersen PK, Robinson WH.
Arthritis Res Ther.
2009;
11
(3):
R76
-
Efficacy of a p38 mitogen activated protein kinase inhibitor in mitigating an established inflammatory reaction to polyethylene particles in vivo.
Ma T,
Ren PG, Larsen DM, Suenaga E, Zilber S, Genovese M, Smith RL, Goodman SB.
J Biomed Mater Res A.
2009;
89
(1):
117-23
-
First report of idiopathic granulomatous mastitis treated with methotrexate monotherapy.
Schmajuk G,
Genovese MC.
J Rheumatol.
2009;
36
(7):
1559-60
-
Inhibition of p38: has the fat lady sung?
Genovese MC,
Arthritis Rheum.
2009;
60
(2):
317-20
-
Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis.
Emery P,
Genovese MC, van Vollenhoven R, Sharp JT, Patra K, Sasso EH.
J Rheumatol.
2009;
36
(7):
1429-41
-
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.
Genovese MC,
Breedveld FC, Emery P, Cohen S, Keystone E, Matteson EL, Baptiste Y, Chai A, Burke L, Reiss W, Sweetser M, Shaw TM.
Ann Rheum Dis.
2009;
68
(12):
1894-7
-
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.
Genovese MC,
Schiff M, Luggen M, Becker JC, Aranda R, Teng J, Li T, Schmidely N, Le Bars M, Dougados M.
Ann Rheum Dis.
2008;
67
(4):
547-54
-
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
Genovese MC,
McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, Woodworth T, Gomez-Reino JJ.
Arthritis Rheum.
2008;
58
(10):
2968-80
-
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Genovese MC,
Kaine JL, Lowenstein MB, Del Giudice J, Baldassare A, Schechtman J, Fudman E, Kohen M, Gujrathi S, Trapp RG, Sweiss NJ, Spaniolo G, Dummer W.
Arthritis Rheum.
2008;
58
(9):
2652-61
-
Efficacy results from pivotal clinical trials with abatacept.
Rozelle AL,
Genovese MC.
Clin Exp Rheumatol.
2007 Sep-Oct;
25
(5 Suppl 46):
S30-4
-
A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.
Magnano MD,
Chakravarty EF, Broudy C, Chung L, Kelman A, Hillygus J, Genovese MC.
J Rheumatol.
2007;
34
(6):
1323-7
-
A pilot trial of rituximab in the treatment of patients with dermatomyositis.
Chung L,
Genovese MC, Fiorentino DF.
Arch Dermatol.
2007;
143
(6):
763-7
-
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines.
Hueber W,
Tomooka BH, Zhao X, Kidd BA, Drijfhout JW, Fries JF, van Venrooij WJ, Metzger AL, Genovese MC, Robinson WH.
Ann Rheum Dis.
2007;
66
(6):
712-9
-
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
Genovese MC,
Mease PJ, Thomson GT, Kivitz AJ, Perdok RJ, Weinberg MA, Medich J, Sasso EH.
J Rheumatol.
2007;
34
(5):
1040-50
-
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
Paniagua RT,
Sharpe O, Ho PP, Chan SM, Chang A, Higgins JP, Tomooka BH, Thomas FM, Song JJ, Goodman SB, Lee DM, Genovese MC, Utz PJ, Steinman L, Robinson WH.
J Clin Invest.
2006;
116
(10):
2633-42
-
A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.
Genovese MC,
Chakravarty EF, Boyle DL, Tutuncu Z, Thorburn CM, Halilhodzic M, Kroll S, Baughman J, Stewart S, Kavanaugh A.
J Rheumatol.
2005;
32
(12):
2345-50
-
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
Genovese MC,
Becker JC, Schiff M, Luggen M, Sherrer Y, Kremer J, Birbara C, Box J, Natarajan K, Nuamah I, Li T, Aranda R, Hagerty DT, Dougados M.
N Engl J Med.
2005;
353
(11):
1114-23
-
Antigen microarray profiling of autoantibodies in rheumatoid arthritis.
Hueber W,
Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF, Sønderstrup G, Monach P, Drijfhout JW, van Venrooij WJ, Utz PJ, Genovese MC, Robinson WH.
Arthritis Rheum.
2005;
52
(9):
2645-55
-
Biologic therapies in clinical development for the treatment of rheumatoid arthritis.
Genovese MC,
J Clin Rheumatol.
2005;
11
(3 Suppl):
S45-54
-
Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus.
Chakravarty EF,
Colón I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, Druzin ML.
Am J Obstet Gynecol.
2005;
192
(6):
1897-904
-
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.
Genovese MC,
Bathon JM, Fleischmann RM, Moreland LW, Martin RW, Whitmore JB, Tsuji WH, Leff JA.
J Rheumatol.
2005;
32
(7):
1232-42
-
Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis.
Magnano MD,
Genovese MC.
Curr Rheumatol Rep.
2005;
7
(5):
407-15
-
Pharmacologic modulation of periprosthetic osteolysis.
Goodman SB,
Trindade M, Ma T, Genovese M, Smith RL.
Clin Orthop Relat Res.
2005;
(430):
39-45
-
Temporal effects of a COX-2-selective NSAID on bone ingrowth.
Goodman SB,
Ma T, Mitsunaga L, Miyanishi K, Genovese MC, Smith RL.
J Biomed Mater Res A.
2005;
72
(3):
279-87
-
A randomized, controlled trial of interferon-beta-1a (Avonex(R)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626].
Genovese MC,
Chakravarty EF, Krishnan E, Moreland LW.
Arthritis Res Ther.
2004;
6
(1):
R73-R77
-
Associations between rheumatoid arthritis and malignancy.
Chakravarty EF,
Genovese MC.
Rheum Dis Clin North Am.
2004;
30
(2):
271-84, vi
-
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Genovese MC,
Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P.
Arthritis Rheum.
2004;
50
(5):
1412-9
-
Treatment of rheumatoid arthritis with etanercept.
Genovese MC,
Kremer JM.
Rheum Dis Clin North Am.
2004;
30
(2):
311-28, vi-vii
-
Unlocking the "PAD" lock on rheumatoid arthritis.
Utz PJ,
Genovese MC, Robinson WH.
Ann Rheum Dis.
2004;
63
(4):
330-2
-
COX-2 selective inhibitors and bone.
Goodman SB,
Ma T, Genovese M, Lane Smith R.
Int J Immunopathol Pharmacol.
2003 Sep-Dec;
16
(3):
201-5
-
Imaging of the articular cartilage in osteoarthritis of the knee joint: 3D spatial-spectral spoiled gradient-echo vs. fat-suppressed 3D spoiled gradient-echo MR imaging.
Yoshioka H,
Alley M, Steines D, Stevens K, Rubesova E, Genovese M, Dillingham MF, Lang P.
J Magn Reson Imaging.
2003;
18
(1):
66-71
-
Interleukin 1 receptor antagonist inhibits localized bone formation in vivo.
Ma T,
Miyanishi K, Trindade MC, Genovese M, Regula D, Smith RL, Goodman SB.
J Rheumatol.
2003;
30
(12):
2547-52
-
Modulation of bone ingrowth and tissue differentiation by local infusion of interleukin-10 in the presence of ultra-high molecular weight polyethylene (UHMWPE) wear particles.
Goodman S,
Trindade M, Ma T, Lee M, Wang N, Ikenou T, Matsuura I, Miyanishi K, Fox N, Regula D, Genovese M, Klein J, Bloch D, Smith RL.
J Biomed Mater Res A.
2003;
65
(1):
43-50
-
Rheumatic syndromes associated with malignancy.
Chakravarty E,
Genovese MC.
Curr Opin Rheumatol.
2003;
15
(1):
35-43
-
Autoantigen microarrays for multiplex characterization of autoantibody responses.
Robinson WH,
DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, Fournel S, Fong D, Genovese MC, de Vegvar HE, Skriner K, Hirschberg DL, Morris RI, Muller S, Pruijn GJ, van Venrooij WJ, Smolen JS, Brown PO, Steinman L, Utz PJ.
Nat Med.
2002;
8
(3):
295-301
-
COX-2 selective NSAID decreases bone ingrowth in vivo.
Goodman S,
Ma T, Trindade M, Ikenoue T, Matsuura I, Wong N, Fox N, Genovese M, Regula D, Smith RL.
J Orthop Res.
2002;
20
(6):
1164-9
-
Central nervous system lupus and pregnancy: 11-year experience at a single center.
El-Sayed YY,
Lu EJ, Genovese MC, Lambert RE, Chitkara U, Druzin ML.
J Matern Fetal Neonatal Med.
2002;
12
(2):
99-103
-
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Genovese MC,
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Cannon GW, Spencer-Green G, Finck BK.
Arthritis Rheum.
2002;
46
(6):
1443-50
-
Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes.
Kunkel EJ,
Boisvert J, Murphy K, Vierra MA, Genovese MC, Wardlaw AJ, Greenberg HB, Hodge MR, Wu L, Butcher EC, Campbell JJ.
Am J Pathol.
2002;
160
(1):
347-55
-
Long-term followup of patients treated with total lymphoid irradiation for lupus nephritis.
Genovese MC,
Uhrin Z, Bloch DA, Oehlert J, Sibley RK, Myers B, Strober S.
Arthritis Rheum.
2002;
46
(4):
1014-8
-
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential.
Kim CH,
Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, Greenberg HB, Butcher EC.
J Clin Invest.
2001;
107
(5):
595-601
-
Current management of rheumatoid arthritis.
Genovese MC,
Davis JS.
Hosp Pract (1995).
2001;
36
(2):
21-6, 29-30, 35
-
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Robinson WH,
Genovese MC, Moreland LW.
Arthritis Rheum.
2001;
44
(9):
1977-83
-
Rules of chemokine receptor association with T cell polarization in vivo.
Kim CH,
Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC.
J Clin Invest.
2001;
108
(9):
1331-9
-
Treatment of rheumatoid arthritis with total lymphoid irradiation: long-term survival.
Uhrin Z,
Wang BW, Matsuda Y, Strober S, Genovese MC.
Arthritis Rheum.
2001;
44
(7):
1525-8
-
A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues.
Pan J,
Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, Vierra MA, Genovese MC, Butcher EC, Soler D.
J Immunol.
2000;
165
(6):
2943-9
-
Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.
Kunkel EJ,
Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Greenberg HB, Parker CM, Butcher EC, Andrew DP, Agace WW.
J Exp Med.
2000;
192
(5):
761-8
-
A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
van Vollenhoven RF,
Park JL, Genovese MC, West JP, McGuire JL.
Lupus.
1999;
8
(3):
181-7
-
Joint and soft-tissue injection. A useful adjuvant to systemic and local treatment.
Genovese MC,
Postgrad Med.
1998;
103
(2):
125-34
-
Fever, rash, and arthritis in a woman with silicone gel breast implants.
Genovese MC,
West J Med.
1997;
167
(3):
149-58
-
Lemierre's syndrome.
Lee BK,
Lopez F, Genovese M, Loutit JS.
South Med J.
1997;
90
(6):
640-3
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help